Neurontin Purchasers Ask To Amend Class Definition
Direct purchaser plaintiffs seeking class certification in multidistrict litigation accusing Pfizer Inc. of using patent litigation to delay generic competition for epilepsy drug Neurontin have requested to supplement their certification request...To view the full article, register now.
Already a subscriber? Click here to view full article